SYVN1 and triple-negative breast carcinoma: Considering the intrinsic nature of HRD1 as an E3 ubiquitin ligase [23], we implemented a liquid chromatography-mass spectrometry assay in HRD1-overexpressing MDA-MB-231 cells to find out the underlying mechanisms of HRD1 functions and its potential substrates in triple-negative breast cancer.